Linear Health Sciences Reports Clinical, Commercial Milestones
26 Junio 2024 - 6:05AM
Business Wire
A growing number of healthcare providers are
adopting the Orchid SRV IV safety device, with clinical acceptance
rates as high as 97 percent
Medical device company Linear Health Sciences today announced
multiple clinical and commercial milestones for its Orchid SRV™, a
breakaway safety valve designed to improve the use of medical
tubing in hospitals.
More than a dozen clinical sites have evaluated the Orchid
Safety Release Valve, a force-activated safety device designed to
reduce the risk of IV catheter failure and replacement, with
clinical acceptance rates averaging more than 92 percent. Some
30,000 devices have been deployed, and a growing number of
hospitals and healthcare systems are evaluating the Orchid device,
which is indicated for patients two weeks of age and older during
intermittent or continuous infusion.
In one case study, a large regional medical center in the
Northeast adopted the Orchid SRV after its evaluation showed
annualized cost savings of nearly $104,000, and resulted in a
clinical acceptance rate of more than 97 percent.
“Our team has accomplished a remarkable amount in the two years
since the Orchid SRV earned its latest FDA clearance, and there is
much more to come, as an increasing number of healthcare providers
recognize the benefits of addressing tension-based failures in
vascular access and the need to deploy new tools in the fight
against disruptions in care,” said Linear Health Sciences CEO Dan
Clark. “I’m grateful for the team’s hard work and dedication as we
continue to improve safety for patients and caregivers, streamline
hospital workflows, and – most importantly – help improve patient
outcomes.”
Clinical staff largely delivered positive feedback after
trialing the Orchid SRV, including:
- “Worked great with one of my patients that had pulled his line
4 times prior to the trial. Applied an Orchid and saved his line 3
times, this is the best invention ever."
- "Saved my line 3 times on a confused patient."
- “Product saved my line on a confused patient who is not able to
be verbally redirected.”
- “Great resource/tool to have to maintain IV lines, looking
forward to utilizing this product.”
- "Occlusion alarming on pump, patient’s dad picked her up AND
moved her to a chair, caused the line tension break. No issue
priming/replacing Orchid.”
- "It was easy to use and see in the patient's bed after the
occlusion alarm went off."
- "Felt comfortable with my patient trying to hold his
lines."
- “[Lactated Ringers] infusing patient detached two times, Orchid
in place IV preserved.”
- "This is an insurance policy for my access line – very easy to
use and can see it being very helpful in workflow."
Dislodgement is most frequently caused by patient confusion or
removal of the catheter, loose dressing or tape, and/or tubing
becoming tangled in bed linens. The estimated 5 million U.S.
dislodgement events per year are projected to cost $2 billion
annually.
The Orchid SRV is placed between the existing IV extension set
and general IV administration tubing. When a tension event occurs
on the IV line activating the SRV, the valve disconnects, separates
and seals off both sides of the IV, creating a sterile barrier.
Linear Health Sciences won an Innovative Technology Award for
the Orchid SRV from group purchasing organization Vizient, a
national group purchasing agreement for the IV Therapy - Needleless
Connectors category with Premier, and recently signed a contract
with the U.S. Dept. of Veterans Affairs (VA) and GS2 (Government
Solutions & Services), enabling the VA system to evaluate,
adopt, and purchase the Orchid SRV.
About Linear Health Sciences
Linear Health Sciences is a medical device company that
developed proprietary, breakaway safety valve technology designed
to improve the use of medical tubing in hospitals. The platform
technology was developed to increase the safety and satisfaction of
patients, caregivers, and healthcare facilities, while dramatically
reducing costs. The company’s initial products include the Orchid
SRV for use in IV catheter therapy and the Orchid SRV Type D device
for use in surgical/wound, nephrostomy and abscess drainage. For
more information, visit linearsciences.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240626431698/en/
Sam Choinski Pazanga Health Communications
schoinski@pazangahealth.com (860) 301-5058